Dallah Healthcare Company Announces the Results of the Extraordinary General Assembly’s Meeting Which Includes the Approving Increase (First Meeting)
| Element List | Explanation |
|---|---|
| Introduction | Dallah Healthcare Company’s (“Dallah” or the “Company”) board of directors is pleased to announce the results of the extraordinary general assembly meeting (the “EGM”) which took place at 9:00 pm on Wednesday 12/09/1446H (corresponding to 12/03/2025G) which included the increase of the Company’s capital (first meeting) remotely by means of contemporary technology using Tadawulaty platform. |
| City and Location of the Extraordinary General Assembly's Meeting | Through contemporary technology from the Company’s headquarter in Riyadh (using only Tadawulaty system). |
| Date of the Extraordinary General Assembly's Meeting | 2025-03-12 Corresponding to 1446-09-12 |
| Time of the General Assembly’s Meeting | 21:00 |
| Percentage of Attending Shareholders | 81.28% |
| Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees | The EGM was attended by board members as follows:
1. Eng. Tarek bin Othman Alkassabi (Chairman) 2. Mr. Muhei Addein Saleh Kamel (Vice Chairman) 3. Eng. Mohammed bin Nabil Hefny 4. Eng. Talal bin Ibrahim Al Maiman 5. Mr. Abdullah bin Turki Al-Sudairy 6. Mr. Amr bin Mohammed Kamel 7. Mr. Mohammed bin Hamad Al-Solai
The following Dallah Healthcare Board member apologized for not being able to attend the meeting: 1- Dr. Mohammed bin Rashid Al-Faqih 2- Mr. Fahad Bin Abdullah Al-kassim |
| Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Names of Those Attending on their Behalf | 1. Eng. Tarek bin Othman Alkassabi (Chairman of the Investment and Financing Committee)
2. Mr. Mohammed bin Hamad Al-Solai ( Representative of the of the Audit Committee). 3. Mr. Talal bin Ibrahim Al Maiman (Chairman of the Remuneration and Nomination Committee). |
| Voting Results on the Items of the General Assembly's Meeting Agenda's | 1. Approving the increase in Dallah’s capital from nine hundred seventy-six million eight hundred eleven thousand six hundred sixty (SAR 976,811,660) Saudi Riyals to one billion fifteen million seven hundred forty-seven thousand six hundred ninety (SAR 1,015,747,690) Saudi Riyal, and increasing the number of its shares from ninety-seven million six hundred eighty-one thousand one hundred sixty-six (97,681,166) ordinary shares to one hundred one million five hundred seventy-four thousand seven hundred sixty-nine (101,574,769) ordinary shares, representing an increase of 3.99% in Dallah’s current capital, to acquire (a) fourteen million six hundred eleven thousand six hundred (14,611,600) ordinary shares with a nominal value of ten (10) SAR per share in Al-Ahsa Medical Services Company, representing 97.41% of the shares in Al-Ahsa Medical Services Company; and (b) all shares in Al-Salam Medical Services Company, totaling twenty million (20,000,000) ordinary shares with a nominal value of ten (10) SAR per share from the seller, Ayyan Investment Company, in exchange for the issuance of three million eight hundred ninety-three thousand six hundred three (3,893,603) ordinary shares with a nominal value of ten (10) SAR per share, fully paid in accordance with the terms and conditions of the Share Purchase and Subscription Agreement, including approval of (a) the provisions of the Share Purchase and Subscription Agreement, and (b) the proposed amendments to Article (7) of Dallah’s bylaws regarding the capital increase.
2. Approving the amendment of the remuneration policy for Board members, subcommittees, and senior executives. |
| Additional Information | Given that Dallah’s EGM approved the first agenda item, and Ayyan’s ordinary general assembly approved the relevant resolutions regarding the acquisition transaction, the transaction will complete including the increase in Dallah’s capital. For more details about the transaction, its terms and conditions, and all matters related to it, including the related risks and the steps and procedures to complete the transaction, shareholders should refer to the Shareholders’ Circular published by the Company. Dallah will announce the completion of all transaction procedures in due course. |
Comments